Related studies have found that knocking down the HE4 gene in lung cancer can lead to inactivation and downregulation of EGFR expression, thereby inhibiting EGFR downstream signaling pathways and the growth and metastasis of lung cancer cells.32, 33. This evidence concerns the gene WFDC2 and lung carcinoma.